GENERATE
LIVE

Serial Number

98113053

Owner

GENERATE BIOMEDICINES, INC.

Attorney

Jennifer M. Mikulina

Filing Date

Aug 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GENERATE Trademark

Serial Number: 98113053

GENERATE is a trademark filed by GENERATE BIOMEDICINES, INC. on August 2, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

GENERATE BIOMEDICINES, INC. (17 trademarks)

55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

August 2, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical therapeutic preparations, pharmaceutical preparations, medical therapeutics in the nature of pharmaceutical preparations, therapeutic vaccines, and prophylactic vaccines, and medical pharmaceutical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology for treating infectious diseases, cancer, asthma, chronic obstructive pulmonary disease, atopic dermatitis, chronic rhinosinusitis with nasal polyps, inflammatory bowel disease, allergic disease, inflammatory disease, respiratory inflammation or fibrosis, cardiovascular diseases, gout, obesity, neurological conditions, and Sjögren's syndrome, all of the aforesaid developed using artificial intelligence technology

Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity

Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 8, 2026 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 3, 2025 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 7, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 1, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2023 NWOS
NEW APPLICATION ENTERED
Aug 5, 2023 NWAP